High familial risk in nodular lymphocyte-predominant hodgkin lymphoma

Journal of Clinical Oncology

Volumn 31, Issue 7, 2013, Pages 938-943

  Saarinen, Silva ^a   Pukkala, Eero ^b   Vahteristo, Pia ^a   Mäkinen, Markus J ^d   Franssila, Kaarle ^c   Aaltonen, Lauri A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CLASSICAL HODGKIN LYMPHOMA; FEMALE; FIRST DEGREE RELATIVE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR BIOPSY; CANCER DIAGNOSIS; CANCER RISK; LARGE CELL LYMPHOMA; MIXED CELLULARITY HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; POPULATION RESEARCH; PRIMARY TUMOR; STANDARDIZED INCIDENCE RATIO;

ADULT; AGED; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HODGKIN DISEASE; HUMANS; INCIDENCE; LYMPHOCYTES; MALE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84875691603     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.5958     Document Type: Article

References (20)

1. Colby TV, Hoppe RT, Warnke RA Hodgkin's disease A clinicopathologic study of 659 cases. Cancer 491848-1858, 1982.
2. Nogová L, Reineke T, Brillant C, et al Lymphocyte-predominant and classical Hodgkin's lymphoma A comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 26434-439, 2008.
3. Morton LM, Wang SS, Devesa SS, et al Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107265-276, 2006.
4. Harris NL, Jaffe ES, Stein H, et al A revised European-American classification of lymphoid neoplasms A proposal from the International Lymphoma Study Group. Blood 841361-1392, 1994.
5. Al-Mansour M, Connors JM, Gascoyne RD, et al Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol 28793-799, 2010.
6. Lee AI, LaCasce AS Nodular lymphocyte predominant Hodgkin lymphoma. Oncologist 14739- 751, 2009.
7. Mani H, Jaffe ES Hodgkin lymphoma An update on its biology with new insights into classification. Clin Lymphoma Myeloma 9206-216, 2009.
8. Kerzin-Storrar L, Faed MJ, MacGillivray JB, et al Incidence of familial Hodgkin's disease. Br J Cancer 47707-712, 1983.
9. Mack TM, Cozen W, Shibata DK, et al Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 332413-418, 1995.
10. Goldin LR, Pfeiffer RM, Gridley G, et al Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 1001902-1908, 2004.
11. Campbell GN, Lloyd J, Wotherspoon A, et al Nodular lymphocyte predominant Hodgkin lymphoma in siblings. Leuk Lymphoma 45609-611, 2004.
12. Bauduer F, Vassallo J, Delsol G, et al Clustering and anticipation for nodular lymphocyte predominance Hodgkin lymphoma within a French Basque kindred. Br J Haematol 130648-649, 2005.
13. Unal A, Sari I, Deniz K, et al Familial nodular lymphocyte predominant Hodgkin lymphoma Successful treatment with CHOP plus rituximab. Leuk Lymphoma 461613-1617, 2005.
14. Saarinen S, Vahteristo P, Launonen V, et al Analysis of KLHDC8B in familial nodular lymphocyte predominant Hodgkin lymphoma. Br J Haematol 154413-415, 2011.
15. Saarinen S, Aavikko M, Aittomäki K, et al Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood 118493-498, 2011.
16. Teppo L, Pukkala E, Lehtonen M Data quality and quality control of a population-based cancer registry Experience in Finland. Acta Oncol 33365- 369, 1994.
17. Aaltonen LA, Sankila R, Mecklin JP, et al A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev 1857-63, 1994.
18. Aaltonen LA, Salovaara R, Kristo P, et al Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 3381481-1487, 1998.
19. Proctor IE, McNamara C, Rodriguez-Justo M, et al Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network. J Clin Oncol 291431-1435, 2011.
20. Finnish Cancer Registry Cancer in Finland 2008 and 2009. Cancer Society of Finland, Publication No. 84, Helsinki 2011.